OncoSec Medical Selected to Present Phase II Data in Poster Highlights Session at 2014 ASCO Annual Meeting

OncoSec Medical Inc. , a company developing its ImmunoPulse DNA-based immunotherapy to treat solid tumors, will present an update of data from their Phase 2 melanoma study at the American Society of Clinical Oncology’s 50th Annual Meeting, taking place May 30-June 3, 2014, at McCormick Place in Chicago, Illinois.



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1lAj85g

via IFTTT